We utilized immunohistochemistry to evaluate the expression levels of SORT1 in both cancerous tissues and adjacent non‐cancerous tissues obtained from patients diagnosed with lung adenocarcinoma. This evidence concerns the gene SORT1 and lung adenocarcinoma.